Objective To investigate the clinical characteristics and treatment defects in slow-to-recover children with Mycoplasma pneumoniae pneumonia (MPP) associated with airway mucous plug formation, and to provide a basis for prognostic judgment and therapeutic guidance. Methods A retrospective analysis was performed on the clinical data of 67 children with MPP who were admitted between May 2012 and May 2014 and showed airway mucous plug formation in fiberoptic bronchoscope examinations. Based on the results of re-examinations using imaging methods, all patients were classified into a slow-to-recover group (n=30) and a control group (n=37). Comparisons of clinical outcomes, laboratory indices, imaging findings, and treatment methods were performed between the two groups. The receiver operating characteristic (ROC) curves were drawn to analyze the indices with significant differences. Results The percentage of neutrophils, levels of C-reactive protein (CRP), lactic dehydrogenase (LDH), fibrinogen (FIB), and IgM in peripheral blood, and incidence of pleural effusion were significantly higher in the slow-to-recover group than in the control group (P<0.05). The fever duration and treatment time of azithromycin and fiberoptic bronchoscope for the first time were significantly longer in the slow-to-recover group than in the control group (P<0.05). The results of ROC curve analysis showed that the optimal cut-off points of fever duration, percentage of neutrophils, levels of CRP and FIB, and treatment time of fiberoptic bronchoscope for the first time were 11.5 days, 70.7%, 57 mg/L, 4.7 g/L, and 13.5 days, respectively, with sensitivity and specificity higher than 0.643 and 0.727. Conclusions The fever duration, percentage of neutrophils, level of CRP, level of FIB, and treatment time of fiberoptic bronchoscope for the first time can predict a recovery time longer than two months in children with MPP associated with mucous plug formation.
Key words
Mycoplasma pneumoniae pneumonia /
Mucous plug /
Prognosis /
Receiver operating characteristic curve /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Zhao H, Li S, Cao L, et al. Surveillance of Mycoplasma pneumoniae infection among children in Beijing from 2007 to 2012[J]. Chin Med J (Engl), 2014, 127(7): 1244-1248.
[2] Miyashita N, Obase Y, Ouchi K, et al. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit[J]. J Med Microbiol, 2007, 56(Pt 12): 1625-1629.
[3] 胡英惠, 焦安夏. 小儿内生性支气管异物的临床特点及支气管镜术的应用[J]. 中国当代儿科杂志, 2010, 12(9): 712-714.
[4] 焦安夏, 饶小春, 江沁波, 等. 迁延与非迁延性肺炎支原体肺炎患儿气道黏膜损害特点的对照研究[J]. 中国循证儿科杂志, 2010, 5(2): 111-115.
[5] 胡亚美, 江载芳. 诸福棠实用儿科学[M]. 第7版. 北京: 人民卫生出版社, 2002: 1204-1205.
[6] 左慧敏, 刘秀云, 江载芳. 肺炎支原体肺炎患儿发生后遗症的危险因素研究[J]. 临床儿科杂志, 2008, 26(7): 566-569.
[7] Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen[J]. Clin Microbiol Rev, 2004, 17(4): 697-728.
[8] Narita M, Tanaka H. Late increase of interleukin-18 levels in blood during Mycoplasma pneumoniae pneumonia[J]. Cytokine, 2012, 59(1): 18-19.
[9] Arae K, Hirata M, Kurata S, et al. Mycoplasma pneumoniae induces interleukin-8 production via the epidermal growth factor receptor pathway[J]. Microbiol Immunol, 2011, 55(10): 748-750.
[10] 李素荣, 牟京辉, 常丽, 等. 肺炎支原体感染所致儿童坏死性肺炎30例胸部CT表现及转归[J]. 中华儿科杂志, 2013, 51(3): 211-215.
[11] Daxboeck F, Eisl B, Burghuber C, et al. Fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl[J]. Wien Klin Wochenschr, 2007, 119(11-12): 379-384.
[12] Oishi T, Narita M, Matsui K, et al. Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia[J]. J Infect Chemother, 2011, 17(6): 803-806.
[13] Loens K, Goossens H, Ieven M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods[J]. Eur J Clin Microbiol Infect Dis, 2010, 29(9): 1055-1069.
[14] Narita M, Tanaka H, Yamada S, et al. Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection[J]. Clin Diagn Lab Immunol, 2001, 8(5): 1028-1030.
[15] 刘金荣, 彭云, 杨海明, 等. 难治性肺炎支原体肺炎的表现特征和判断指标探讨[J]. 中华儿科杂志, 2012, 50(12): 915-918.
[16] Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America[J]. Clin Infect Dis, 2011, 53(7): e25-e76.
[17] Stahl JE, Barza M, DesJardin J, et al. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia[J]. Arch Intern Med, 1999, 159(21): 2576-2580.
[18] 焦安夏. 支气管镜术在难治性肺炎支原体肺炎诊治中的应用[J]. 实用儿科临床杂志, 2012, 27(4): 240-241.
[19] 倪彩云, 刘霞, 马静, 等. 支气管镜下冷冻治疗儿童肉芽及瘢痕组织导致的下气道狭窄及阻塞22例[J]. 中华儿科杂志, 2012, 50(1): 45-49.
[20] Lu A, Wang L, Zhang X, et al. Combined treatment for child refractory Mycoplasma pneumoniae pneumonia with ciprofloxacin and glucocorticoid[J]. Pediatr Pulmonol, 2011, 46(11): 1093-1097.
[21] 吴跃进, 孙节, 张建华, 等. 糖皮质激素辅助治疗儿童肺炎支原体大叶性肺炎的疗效[J]. 中国当代儿科杂志, 2014, 16(4): 401-405.
[22] Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children[J]. Korean J Pediatr, 2012, 55(2): 42-47.
PDF(1356 KB)
